. 2019 Jan 14;54(6):530–540. doi: 10.1007/s00535-018-01545-7

Table 2.

Summary of adverse drug reactions in each group

	Placebo, n (%)	SK-1202, n (%)
	Placebo, n (%)	13 g/day	26 g/day	39 g/day
	n = 62	n = 63	n = 63	n = 62
At least one ADR	6 (9.7)	2 (3.2)	4 (6.3)	13 (21.0)
Gastrointestinal disorders^a
Abdominal distension	0 (0.0)	1 (1.6)	1 (1.6)	2 (3.2)
Abdominal pain	2 (3.2)	0 (0.0)	1 (1.6)	2 (3.2)
Diarrhea	0 (0.0)	0 (0.0)	0 (0.0)	6 (9.7)
Gastrointestinal sounds abnormal	0 (0.0)	0 (0.0)	1 (1.6)	2 (3.2)
Investigations^a
Protein total decreased	2 (3.2)	0 (0.0)	0 (0.0)	0 (0.0)

ADR adverse drug reaction

^aAdverse drug reactions reported by more than 2% of subjects in any group are shown